Several high-profile lawsuits are targeting weight loss and diabetes drugs due to severe side effects. The Ozempic lawsuit focuses on severe gastrointestinal issues, like stomach paralysis, with claims that the manufacturer failed to provide adequate warnings. The Wegovy lawsuit centers on thyroid cancer risks, arguing insufficient evidence of long-term safety. Mounjaro lawsuits cite pancreatitis and severe stomach pain, alleging that risks were downplayed. Rybelsus lawsuits highlight nausea and vomiting, claiming inadequate disclosure of dangers. The Trulicity lawsuit primarily links the drug to severe gastrointestinal problems, pancreatitis, and thyroid cancer, with allegations that the manufacturer failed to sufficiently communicate these serious risks to patients. Additionally, the Novo Nordisk lawsuit involves multiple drugs, accusing the company of prioritizing profits over safety by neglecting to warn about severe health risks. These prominent cases reflect the broader legal battles as patients seek compensation for the harm caused by these medications.